Feeling Less Anxious About Anxiolytics: Answering a Provider's Questions
Episode notes
It’s another listener-requested episode, and this time we’re turning our attention to anxiolytics in correctional settings.
Chris provides a quick 101 on anxiolytics as a class and their outsized significance in correctional health care before addressing some very practical physician questions: Are Atarax and Vistaril truly different? Does buspirone actually work? Why does benzodiazepine monotherapy persist despite guideline recommendations? What SSRIs are better for anxiety than others? And so much more.
Before that, Chris covers several important medication and regulatory updates, including the first-ever Cardiovascular-Kidney-Metabolic (CKM) Syndrome guideline, the FDA approval of Simtriyo for ADHD, new international guidance on low-level HIV viremia, and emerging concerns surrounding compounded peptide therapies.
We wrap things up with a fascinating look back at Miltown (meprobamate), the first “blockbuster” anxiolytic drug.
Link to the full show notes with references for further reading.
Sponsor Links:
Music in this Episode:
The Retro Synth by Art Haiz
Vitals & Headlines (Suno AI)
Breezy Thoughts (Suno AI)
Trivia Time Ticker (Suno AI)